Peptide data sheet
GHRP-6
Performance · Growth Hormone Releasing Peptide-6 · GHRP6 · SKF-110679
Verdict
unprovenas a physique or aging-related agent
Quick answer
GHRP-6 is a synthetic growth hormone releasing peptide that acts on the ghrelin receptor to prompt the pituitary to release growth hormone. Early human studies measured short-term rises in GH markers, and it is especially noted for a strong increase in appetite. It is not FDA-approved, is sold for research use only, and reported effects include intense hunger, water retention, and modest rises in cortisol and prolactin. The verdict stays Unproven for physique or aging-related use.
- Class
- Growth hormone secretagogue (ghrelin-receptor agonist)
- Half-life
- Short — roughly 15 to 30 minutes reported in pharmacokinetic studies
- FDA status
- Not FDA-approved; sold for research use only
- WADA banned?
- Yes
Which form actually works?
Injectable (research vial)
Unproven
The form studied in the human GH-response literature. It moves GH markers short-term and reliably increases appetite, but human data on physique or aging-related outcomes is missing, and sourcing is gray-market.
Oral / nasal
Unproven
Occasionally marketed in these forms, but peptide bioavailability by these routes is poorly characterized and there is little supporting human data. Considered unproven.